1tlm

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The crystal structure of human transthyretin (TTR) complexed with, milrinone (2-methyl-5-cyano-3,4'-bipyridin-6(1H)-one), a positive, inotropic cardiac agent, has been refined to R = 17.4% for 8-1.9-A, resolution data. This report provides the first detailed description of, protein interactions for an inotropic bipyridine agent which is an, effective thyroid hormone binding competitor to transthyretin. Milrinone, is bound along the 2-fold axis in the binding site with its substituted, pyridone ring located deep within the channel of the two identical binding, domains of the TTR tetramer. In this orientation the 5-cyano group, occupies the same site as the 3'-iodine in the TTR complex with, 3,3'-diiodothyronine (Wojtczak, A., Luft, J., and Cody, V. (1992) J. Biol., Chem. 267, 353-357), which is 3.5 A deeper in the channel than thyroxine, (Blake, C. C. F., and Oately, S. J., (1977) Nature 268, 115-120). These, structural results confirm computer modeling studies of milrinone, structural homology with thyroxine and its TTR binding interactions and, explain the effectiveness of milrinone competition for thyroxine binding, to TTR. To understand the weaker binding affinity of the parent inotropic, drug, amrinone (5-amino-3,4'-bipyridin-6(1H)-one), modeling studies of its, TTR binding were carried out which indicate that the 5-amino group cannot, participate in strong interactions with TTR and the lack of the 2-methyl, further weakens amrinone binding.
+
The crystal structure of human transthyretin (TTR) complexed with milrinone (2-methyl-5-cyano-3,4'-bipyridin-6(1H)-one), a positive inotropic cardiac agent, has been refined to R = 17.4% for 8-1.9-A resolution data. This report provides the first detailed description of protein interactions for an inotropic bipyridine agent which is an effective thyroid hormone binding competitor to transthyretin. Milrinone is bound along the 2-fold axis in the binding site with its substituted pyridone ring located deep within the channel of the two identical binding domains of the TTR tetramer. In this orientation the 5-cyano group occupies the same site as the 3'-iodine in the TTR complex with 3,3'-diiodothyronine (Wojtczak, A., Luft, J., and Cody, V. (1992) J. Biol. Chem. 267, 353-357), which is 3.5 A deeper in the channel than thyroxine (Blake, C. C. F., and Oately, S. J., (1977) Nature 268, 115-120). These structural results confirm computer modeling studies of milrinone structural homology with thyroxine and its TTR binding interactions and explain the effectiveness of milrinone competition for thyroxine binding to TTR. To understand the weaker binding affinity of the parent inotropic drug, amrinone (5-amino-3,4'-bipyridin-6(1H)-one), modeling studies of its TTR binding were carried out which indicate that the 5-amino group cannot participate in strong interactions with TTR and the lack of the 2-methyl further weakens amrinone binding.
==Disease==
==Disease==
Line 22: Line 22:
[[Category: transport(thyroxine)]]
[[Category: transport(thyroxine)]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:57:42 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:14:51 2008''

Revision as of 13:14, 21 February 2008


1tlm, resolution 1.9Å

Drag the structure with the mouse to rotate

STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX

Contents

Overview

The crystal structure of human transthyretin (TTR) complexed with milrinone (2-methyl-5-cyano-3,4'-bipyridin-6(1H)-one), a positive inotropic cardiac agent, has been refined to R = 17.4% for 8-1.9-A resolution data. This report provides the first detailed description of protein interactions for an inotropic bipyridine agent which is an effective thyroid hormone binding competitor to transthyretin. Milrinone is bound along the 2-fold axis in the binding site with its substituted pyridone ring located deep within the channel of the two identical binding domains of the TTR tetramer. In this orientation the 5-cyano group occupies the same site as the 3'-iodine in the TTR complex with 3,3'-diiodothyronine (Wojtczak, A., Luft, J., and Cody, V. (1992) J. Biol. Chem. 267, 353-357), which is 3.5 A deeper in the channel than thyroxine (Blake, C. C. F., and Oately, S. J., (1977) Nature 268, 115-120). These structural results confirm computer modeling studies of milrinone structural homology with thyroxine and its TTR binding interactions and explain the effectiveness of milrinone competition for thyroxine binding to TTR. To understand the weaker binding affinity of the parent inotropic drug, amrinone (5-amino-3,4'-bipyridin-6(1H)-one), modeling studies of its TTR binding were carried out which indicate that the 5-amino group cannot participate in strong interactions with TTR and the lack of the 2-methyl further weakens amrinone binding.

Disease

Known diseases associated with this structure: Amyloid neuropathy, familial, several allelic types OMIM:[176300], Amyloidosis, senile systemic OMIM:[176300], Carpal tunnel syndrome, familial OMIM:[176300], Dystransthyretinemic hyperthyroxinemia OMIM:[176300]

About this Structure

1TLM is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complex., Wojtczak A, Luft JR, Cody V, J Biol Chem. 1993 Mar 25;268(9):6202-6. PMID:8454595

Page seeded by OCA on Thu Feb 21 15:14:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools